Dr. Edward Behrens received his undergraduate training at The Johns Hopkins University where he majored in biology. He attended medical school at The University of Pennsylvania where he received the prestigious Howard Hughes Medical Institutes Medical Student Research Fellowship to train in the laboratory of Dr. Philip Cohen. After medical school, Ed completed a Pediatrics Residency and Pediatric Rheumatology Fellowship at The Children's Hospital of Philadelphia. He performed two post-doctoral fellowships in the laboratories of Stefania Gallucci and Gary Koretzky, after which he joined the faculty of the Division of Rheumatology at CHOP as an Assistant Professor in 2009. Ed's research interest is the pathogenesis and treatment of cytokine storm syndromes, including the hemophagocytic syndromes Hemophagocytic Lymphohistiocytosis (HLH) and Macrophage Activation Syndrome (MAS).

Ed Oberle, MD, RhMSUS, is an Assistant Professor of Clinical Pediatrics, Division of Rheumatology at Nationwide Children's Hospital and The Ohio State University College of Medicine. He is also the Director of Rheumatology Musculoskeletal Ultrasound. Dr. Oberle completed his medical training at the Medical College of Wisconsin and completed pediatric residency and pediatric rheumatology fellowship at Children's Hospital of Wisconsin. While he specializes in the care of children with all rheumatologic disorders, his main area of clinical and research interest is in the care and treatment of children with Juvenile Idiopathic Arthritis (JIA). He runs the musculoskeletal (MSK) ultrasound clinic at NCH and teaches MSK ultrasound to medical students at Ohio State. He serves as an education mentor for USSONAR. He is also a member of the Childhood Arthritis and Rheumatology Research Alliance (CARRA) and a cofounder of the ultrasound research group.

Dr. Ekemini Ogbu is a pediatric rheumatologist and physician-scientist. She is an Assistant Professor of Pediatrics at Cincinnati Children’s Hospital Medical Center and University of Cincinnati. She is the Interim Director for the Cincinnati Children’s Multiple Sclerosis and Neuroimmunology Center.

Dr. Ogbu is also an Adjunct Assistant Professor of Pediatrics at Johns Hopkins University School of Medicine. Dr. Ogbu conducts clinical and translational research in neuropsychiatric lupus, and hematologic associations of systemic lupus in children.

This includes her ongoing work in cerebrovascular disease and cognitive dysfunction in childhood-onset lupus. Dr. Ogbu co-leads the neuropsychiatric lupus workgroup of the Childhood Arthritis and Rheumatology Research Alliance.

She is also involved in a number of rheumatology clinical trials at the Cleveland Clinic focusing on osteoarthritis, psoriatic arthritis, and rheumatoid arthritis including the PRECISION trial. This trial focuses on the cardiovascular risks associated among 3 common NSAIDs , ibuprofen, naproxen, and celecoxib. She is a past recipient of the Physician Scientist Development Award and Clinical Investigator Award by the American College of Rheumatology for her research and funded by the National Psoriasis Foundation (NPF) and the Arthritis Foundation. Her research is also funded by an NIH RO1 grant. She is on the Board of Directors of the NPF, a Board Member of the Rheumatology Research Foundation, and a member of the ACR Guidelines Committee.

Elana J. Bernstein, MD, MSc, is The Florence Irving Associate Professor of Medicine in the Division of Rheumatology at Columbia University Vagelos College of Physicians and Surgeons and Director of the Columbia University Scleroderma Center. Dr. Bernstein’s research focuses on lung disease in systemic sclerosis, post-lung transplant outcomes of adults with systemic autoimmune rheumatic diseases, and the relationship between autoimmunity and interstitial lung disease. Dr. Bernstein has received grants from the National Institutes of Health, Department of Defense, Rheumatology Research Foundation, and Arthritis Foundation to study lung disease in systemic sclerosis.

Dr. Eli Miloslavsky is an Associate Professor of Medicine at the Massachusetts General Hospital where he completed his Internal Medicine residency and Rheumatology fellowship. Dr. Miloslavsky's areas of expertise include vasculitis and medical education. His leadership roles have included course and clerkship director, curriculum phase director at Harvard Medical School and firm chief in the MGH Internal Medicine residency. Dr. Miloslavsky’s medical education research interests include the resident-fellow consultation dynamic, student clerkship experience, feedback and evaluation.

Dr. Emily von Scheven, Professor of Pediatrics, is a board-certified pediatric rheumatologist with a special interest in the long-term outcomes of children with chronic illness. 

She serves as UCSF Pediatric Rheumatology Division Chief, directs the UCSF Child and Adolescent Comprehensive Lupus Program for Improved Health and is the founding Director for the UCSF Wellness Center for Youth with Chronic Conditions.

She also serves as past-President of the Childhood Arthritis and Rheumatology Research Alliance (CARRA).

Dr. Ruderman received his undergraduate degree in English literature from Princeton University and his medical degree from the Albert Einstein College of Medicine. After a residency in internal medicine at the Hospital of the University of Pennsylvania, he completed a rheumatology fellowship at Brigham and Women's Hospital, with a concurrent research fellowship at the Harvard School of Public Health. He joined the faculty at Northwestern University in 2000, where he is currently a Professor of Medicine and Associate Chief for Clinical Affairs of the Division of Rheumatology. He is co-director of a cooperative clinic for the management of psoriasis and psoriatic arthritis. Dr. Ruderman is a past president of the Chicago Rheumatism Society. He has served as principal investigator on over 50 clinical trials, and he is involved in several projects that link clinical practice and the research agenda in the rheumatology clinic. He also serves on the data safety monitoring boards for several international, multicenter, clinical trials in rheumatology. In addition to his research efforts, Dr. Ruderman serves as a vice-chair of Northwestern University's institutional review board. He is a past-chair of the Communications and Marketing Committee of the American College of Rheumatology and a current member of the ACR Board of Directors. Dr. Ruderman is a past member of the Scientific Advisory Council of the Rheumatology Research Foundation and is the deputy editor-in-chief for the Journal of Rheumatology.

Dr. Lawson is a pediatric rheumatologist and medical educator at the University of California, San Francisco, where she joined the faculty in 2013. She provides care to children, teens and young adults with chronic rheumatic disease. Dr. Lawson serves as Program Director for the UCSF Pediatric Rheumatology Fellowship, and Pediatric Clerkship Director for the UCSF School of Medicine. Her main research interest is the improvement of long-term outcomes and access to care for individuals with childhood-onset chronic illness, with a focus on health disparities.

As a dual trained rheumatologist and pulmonary-critical care physician, I do translational research in myositis related interstitial lung disease and have a strong clinical interest in life threatening rheumatic disease.